Aesica has secured a Technology Strategy Board grant to fund a high-value chemical manufacturing process with the winning process set to improve the sustainability of an active pharmaceutical Ingredient (API).
in-PharmaTechnologist brings you a round-up of the latest new facilities and expansions for drugsmakers, including added cytotoxic capabilities for BTL, Jubilant’s launch of a special economic zone in India and plans for a $20m API plant for Omkar.
Lanxess has signalled its intentions for the future by investing €35m ($43m) to expand its German Basic Chemicals business unit in a move that is set to make the firm one of Europe’s biggest active pharmaceutical ingredients (API) producers.
Active pharmaceutical ingredient specialist Calyx Chemicals and Pharmaceuticals is planning an acquisition within the next two years, probably in the US or Europe, according to chief executive Smitesh Shah.
Members of the Synthetic Organic Chemical Manufacturers Association
(SOCMA) have slammed competitors from emerging markets, claiming
poor quality goods and lack of technological competence in regions
such as China, India and Eastern...
A delegation from the Scotland's chemicals industry descended on
the recent Informex trade show in New Orleans, determined to
convince the assembled industry representatives that the country
should be at the top of the list for...
One of the most influential medical journals, The Lancet,
has weighed into the European REACH chemicals debate, which is at
near boiling point as the draft legislation approaches its final
approval date in December.
The stage is ready for the biggest acquisition in BASF's 140-year
history after Engelhard's management agreed to recommend their
shareholders accept the German chemical group's $5bn (€3.8bn)
Chemicals and nutrition group DSM has reported strong profits for
the first quarter in 2006, including in its pharma business, as
higher prices and lower costs have helped it overcome the increase
in raw material costs.
SAFC, a member of the Sigma-Aldrich Group, has launched a supply
solutions business, which aims to combine its Specialties business
with the manufacturing site that was acquired from Degussa last
year. The move is the latest step...
The break up of global fine and specialty chemicals company Avecia
continued as Fujifilm said it would take over Avecia Inkjet
formally next month. The €220 million fee to acquire the company's
Inkjet and Electrophotography...
Fine chemical and pharmaceutical intermediate manufacturers may be
affected by supply disruptions due to ongoing UK shortages of
natural gas. Price spikes in gas are becoming both higher and more
frequent in the UK.
Chemical company Lanxess, release its third quarter results that
show restructuring strategy is bearing fruit, with sales up and the
reduction of net financial debt that is supported by strong growth
in the chemical industry.
The rapporteur trying to finesse the controversial REACH
legislation through the European Parliament, Guido Sacconi, has
formulated a compromise that aims to alleviate fears that the
regulations could pose a heavy financial burden...
Lanxess is to transform its fine chemicals business out into a
legally-discrete subsidiary as part of a programme to increase its
competitiveness in the market for pharmaceutical and agricultural
chemicals, reports Phil Taylor.
Lower sales prices for vitamin C and the feed ingredient lysine ate
into fine chemicals revenue at BASF during the third quarter,
contributing to a 5 per cent decline in sales for this segment,
despite gains in the pharma business.
German chemical company Bayer has posted flat first-quarter 2004
sales, but said that the results were on track given the negative
effects of currency factors. Organic sales growth rose 8.6 per
cent, it claimed, and was driven mainly...